Following the first sale of Yutrepia to treat certain types of PH, Liquidia has received $50 million under its financing ...

Columnist Anna Jeter is delighted to find themes that are relevant to her life in the fictional narratives of writers and ...

A Phase 3 clinical trial testing the experimental daily oral treatment ralinepag in people with PAH has completed enrollment.

Adding Winrevair treatment significantly reduced the risk of clinical worsening in people with a recent PAH diagnosis, per a ...

Gradient Denervation Technologies, a company that makes an ultrasound device for PH, will join an FDA program to speed device ...

With patient enrollment now complete, topline results are expected early next year from a Phase 3 trial testing PAH treatment ...

A fall and subsequent injury left columnist Jen Cueva with lots of downtime to ponder self-care and the importance of ...

Beyond Air has submitted a supplement application for its second-generation LungFit PH 2 device for treating PPHN.